Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Priv.-Doz. Dr. med. James Nagarajah

Klinik für Nuklearmedizin am Universitätsklinkum Essen

Anschrift
Hufelandstr. 55
45122 Essen

Funktionen

  • Nebenberuflich Lehrende/r, Klinik für Nuklearmedizin

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Fizazi, Karim; Morris, Michael J; Shore, Neal D; Chi, Kim N; Crosby, Michael; de Bono, Johann S; Herrmann, Ken; Roubaud, Guilhem; Nagarajah, James; Fleming, Mark; Lewis, Brian; Nordquist, Luke; Carnahan, Natalie; Ghebremariam, Samson; Hertelendi, Marianna; Castellano, Daniel; Sartor, Oliver
    Health-related quality of life, pain, and symptomatic skeletal events with [¹⁷⁷Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore) : An open-label, randomised, phase 3 trial
    In: The Lancet Oncology, Jg. 26, 2025, Nr. 7, S. 948 – 959
    DOI
  • Morris, Michael J.; de Bono, Johann; Nagarajah, James; Sartor, Oliver; Wei, Xiao X.; Nordquist, Luke T.; Koshkin, Vadim S.; Chi, Kim N.; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; Vickers, Adrian; Mirante, Osvaldo; Ghouse, Ray; Fizazi, Karim; Tagawa, Scott T.
    Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer : Analysis of the phase 3 VISION trial
    In: Cancer, Jg. 130, 2024, Nr. 20, S. 3426 – 3435
    DOI (Open Access)
  • Morris, Michael J; Castellano, Daniel; Herrmann, Ken; de Bono, Johann S; Shore, Neal D; Chi, Kim N; Crosby, Michael; Piulats, Josep M; Fléchon, Aude; Wei, Xiao X; Mahammedi, Hakim; Roubaud, Guilhem; Študentová, Hana; Nagarajah, James; Mellado, Begoña; Montesa-Pino, Álvaro; Kpamegan, Euloge; Ghebremariam, Samson; Kreisl, Teri N; Wilke, Celine; Lehnhoff, Katja; Sartor, Oliver; Fizazi, Karim
    ¹⁷⁷Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore) : A phase 3, randomised, controlled trial
    In: Lancet, Jg. 404, 2024, Nr. 10459, S. 1227 – 1239
    DOI
  • Kuo, Phillip H.; Yoo, Don C.; Avery, Ryan; Seltzer, Marc; Calais, Jeremie; Nagarajah, James; Weber, Wolfgang A.; Fendler, Wolfgang P.; Hofman, Michael S.; Krause, Bernd J.; Brackman, Marcia; Kpamegan, Euloge; Ghebremariam, Samson; Benson, Taylor; Catafau, Ana M.; Kendi, Ayse T.
    A VISION Substudy of Reader Agreement on ⁶⁸Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for ¹⁷⁷Lu-PSMA-617 Radioligand Therapy
    In: Journal of Nuclear Medicine (JNM), Jg. 64, 2023, Nr. 8, S. 1259 – 1265
    DOI (Open Access)
  • Fizazi, Karim; Herrmann, Ken; Krause, Bernd J; Rahbar, Kambiz; Chi, Kim N; Morris, Michael J; Sartor, Oliver; Tagawa, Scott T; Kendi, Ayse T; Vogelzang, Nicholas; Calais, Jeremie; Nagarajah, James; Wei, Xiao X; Koshkin, Vadim S; Beauregard, Jean-Mathieu; Chang, Brian; Ghouse, Ray; DeSilvio, Michelle; Messmann, Richard A; de Bono, Johann
    Health-related quality of life and pain outcomes with [¹⁷⁷Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION) : a multicentre, open-label, randomised, phase 3 trial
    In: The Lancet Oncology, Jg. 24, 2023, Nr. 6, S. 597 – 610
    DOI
  • Schmidt, Matthias; Bartenstein, Peter; Bucerius, Jan; Dietlein, Markus; Drzezga, Alexander; Herrmann, Ken; Lapa, Constantin; Lorenz, Kerstin; Musholt, Thomas J.; Nagarajah, James; Reiners, Christoph; Sahlmann, Carsten O.; Kreissl, Michael C.
    Correction: Individualized treatment of differentiated thyroid cancer : The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear Medicine
    In: Nuklearmedizin = Nuclear Medicine, Jg. 61, 2022, Nr. 3, S. 280
    DOI
  • Weber, Manuel; Kersting, David; Riemann, Burkhard; Brandenburg, Tim; Führer, Dagmar; Grünwald, Frank; Kreissl, Michael C.; Dralle, Henning; Weber, Frank; Schmid, Kurt Werner; Herrmann, Ken; Jentzen, Walter; Grafe, Hong; Rischpler, Christoph; Theurer, Sarah; Bockisch, Andreas; Nagarajah, James; Fendler, Wolfgang
    Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI) : A Single-Center Prospective Two-Arm Study
    In: Clinical Cancer Research, Jg. 28, 2022, Nr. 19, S. 4194 – 4202
    DOI (Open Access)
  • Schmidt, Matthias; Bartenstein, Peter; Bucerius, Jan; Dietlein, Markus; Drzezga, Alexander; Herrmann, Ken; Lapa, Constantin; Lorenz, Kerstin; Musholt, Thomas J.; Nagarajah, James; Reiners, Christoph; Sahlmann, Carsten O.; Kreissl, Michael C.
    Individualized treatment of differentiated thyroid cancer : The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear Medicine
    In: Nuklearmedizin = Nuclear Medicine, Jg. 61, 2022, Nr. 02, S. 87 – 96
    DOI (Open Access)
  • Peters, Steffie M. B.; Privé, Bastiaan M.; de Bakker, Maarten; de Lange, Frank; Jentzen, Walter; Eek, Annemarie; Muselaers, Constantijn H. J.; Mehra, Niven; Witjes, J. Alfred; Gotthardt, Martin; Nagarajah, James; Konijnenberg, Mark W.
    Intra-therapeutic dosimetry of [¹⁷⁷Lu]Lu-PSMA-617 in low-volume hormone-sensitive metastatic prostate cancer patients and correlation with treatment outcome
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, Nr. 2, S. 460 – 469
    DOI (Open Access)
  • Peters, Steffie M. B.; Hofferber, Regina; Privé, Bastiaan M.; de Bakker, Maarten; Gotthardt, Martin; Janssen, Marcel; de Lange, Frank; Muselaers, Constantijn H. J.; Mehra, Niven; Witjes, J. Alfred; Costa, Pedro F.; Nagarajah, James; Konijnenberg, Mark W.; Jentzen, Walter
    [⁶⁸Ga]Ga-PSMA-11 PET imaging as a predictor for absorbed doses in organs at risk and small lesions in [¹⁷⁷Lu]Lu-PSMA-617 treatment
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 49, 2022, S. 1101 – 1112
    DOI (Open Access)
  • Kreissl, Michael C.; Janssen, Marcel J.R.; Nagarajah, James
    Current treatment strategies in metastasized differentiated thyroid cancer
    In: Journal of Nuclear Medicine (JNM), Jg. 60, 2019, Nr. 1, S. 9 – 15
    DOI (Open Access)
  • Weber, Manuel; Binse, Ina; Nagarajah, James; Bockisch, Andreas; Herrmann, Ken; Jentzen, Walter
    The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancer
    In: The Quarterly Journal of Nuclear Medicine and Molecular Imaging, Jg. 63, 2019, Nr. 3, S. 235 – 252
    DOI
  • Kreiβl, Michael C.; Jentzen, Walter; Janssen, Marcel; Gotthardt, Martin; Nagarajah, James; Kreißl, Michael C.
    ¹²⁴ J/¹³¹ J-Theranostik des Natrium-Jodid-Symporters beim Schilddrüsenkarzinom
    In: TumorDiagnostik & Therapie, Jg. 40, 2019, Nr. 8, S. 531 – 536
    DOI
  • Ruhlmann, Marcus; Sonnenschein, Wilfried; Nagarajah, James; Binse, Ina; Herrmann, Ken; Jentzen, Walter
    Pretherapeutic 124 i dosimetry reliably predicts intratherapeutic blood kinetics of 131 i in patients with differentiated thyroid carcinoma receiving high therapeutic activities
    In: Nuclear Medicine Communications, Jg. 39, 2018, Nr. 5, S. 457 – 464
    DOI
  • Jentzen, Walter; Phaosricharoen, Jinda; Gomez, Benedikt; Hetkamp, Philipp; Stebner, Vanessa; Binse, Ina; Kinner, Sonja; Herrmann, Ken; Sabet, Amir; Nagarajah, James
    Quantitative performance of ¹²⁴I PET/MR of neck lesions in thyroid cancer patients using ¹²⁴I PET/CT as reference
    In: EJNMMI Physics, Jg. 5, 2018, Nr. 1, 13
    DOI, Online Volltext (Open Access)
  • Boy, Christian; Pöppel, Thorsten; Kotzerke, J.; Krause, B.J.; Amthauer, H.; Baum, R.P.; Buchmann, I.; Ezziddin, S.; Führer, Dagmar; Gabriel, M.; Kuwert, T.; Lahner, Harald; Lauenstein, Thomas; Maecke, H.R.; Nagarajah, James; Rösch, F.; Scheidhauer, K.; Schmidt, M.; Walter, M.A.; Bockisch, Andreas
    Somatostatinrezeptor-PET/CT : Stand: 3/2017 - AWMF-Registernummer: 031-046
    In: Nuklearmedizin = Nuclear Medicine, Jg. 57, 2018, Nr. 1, S. 4 – 17
    DOI (Open Access)
  • Ruhlmann, Verena; Pöppel, Thorsten; Veit, Johannes; Nagarajah, James; Umutlu, Lale; Hoffmann, Thomas K.; Bockisch, Andreas; Herrmann, Ken; Sauerwein, Wolfgang
    Diagnostic accuracy of 18F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma
    In: BMC Cancer, Jg. 17, 2017, Nr. 1, S. 887
    DOI, Online Volltext (Open Access)
  • Nagarajah, James; Janssen, Marcel; Hetkamp, Philipp; Jentzen, Walter
    Iodine symporter targeting with 124I/131I theranostics
    In: Journal of Nuclear Medicine (JNM), Jg. 58, 2017, Nr. Suppl. 2, S. 34S – 38S
    DOI
  • Sawicki, Lino M.; Grüneisen, Johannes; Schaarschmidt, Benedikt M.; Buchbender, Christian; Nagarajah, James; Umutlu, Lale; Antoch, Gerald; Kinner, Sonja
    Evaluation of 18F-FDG PET/MRI, 18F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer
    In: European Journal of Radiology, Jg. 85, 2016, Nr. 2, S. 459 – 465
    DOI
  • Rössing, Ronja; Jentzen, Walter; Nagarajah, James; Bockisch, Andreas; Görges, Rainer
    Serum Thyroglobulin Doubling Time in Progressive Thyroid Cancer
    In: Thyroid, Jg. 26, 2016, Nr. 12, S. 1712 – 1718
    DOI
  • Nagarajah, James; Le, Mina; Knauf, Jeffrey A; Ferrandino, Giuseppe; Montero-Conde, Cristina; Pillarsetty, Nagavarakishore; Bolaender, Alexander; Irwin, Christopher; Krishnamoorthy, Gnana Prakasam; Saqcena, Mahesh; Larson, Steven M; Ho, Alan L; Seshan, Venkatraman; Ishii, Nobuya; Carrasco, Nancy; Rosen, Neal; Weber, Wolfgang A; Fagin, James A
    Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine
    In: The Journal of Clinical Investigation (JCI), Jg. 126, 2016, Nr. 11, S. 4119 – 4124
    DOI
  • Nagarajah, James; Ho, Alan L; Tuttle, R. Michael; Weber, Wolfgang A.; Grewal, Ravinder K.
    Correlation of BRAFV600E Mutation and Glucose Metabolism in Thyroid Cancer Patients : An ¹⁸F-FDG PET Study
    In: Journal of Nuclear Medicine (JNM), Jg. 56, 2015, Nr. 5, S. 662 – 667
    DOI (Open Access)
  • Farahati, Jamshid; Nagarajah, James; Gilman, Elena; Mahjoob, Soha; Zohreh, Moussavi; Rosenbaum-Krumme, Sandra; Bockisch, Andreas; Zakavi, Seyed
    Ethnicity, clothing style, and body mass index are significant predictors of vitamin D insufficiency in Germany
    In: Endocrine Practice, Jg. 21, 2015, Nr. 2, S. 122 – 127
    DOI
  • Altenbernd, Jens-Christian; von der Stein, Ilka; Wetter, Axel; Nagarajah, James; Umutlu, Lale; Heusner, Till Alexander; Theysohn, Jens; Ringelstein, Adrian; Forsting, Michael; Lauenstein, Thomas
    Impact of dual-energy CT prior to radioembolization (RE)
    In: Acta Radiologica, Jg. 56, 2015, Nr. 11, S. 1293 – 1299
    DOI
  • Pöppel, Thorsten; Boy, Christian; Bockisch, Andreas; Kotzerke, J; Buchmann, I; Ezziddin, S; Scheidhauer, K; Krause, B J; Schmidt, D; Amthauer, H; Rösch, F; Nagarajah, James; Führer, Dagmar; Lahner, Harald; Pöpperl, G; Hörsch, D; Walter, M A; Baum, R P
    Peptidrezeptor-Radionuklidtherapie Somatostatinrezeptor-exprimierender Tumore
    In: Nuklearmedizin = Nuclear Medicine, Jg. 54, 2015, Nr. 1, S. 1 – 11
    DOI
  • Grueneisen, Johannes; Nagarajah, James; Buchbender, Christian; Hoffmann, Oliver; Schaarschmidt, Benedikt Michael; Pöppel, Thorsten; Forsting, Michael; Quick, Harald H.; Umutlu, Lale; Kinner, Sonja
    Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer : A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging
    In: Investigative Radiology, Jg. 50, 2015, Nr. 8, S. 505 – 513
    DOI
  • Sabet, Amir; Ezziddin, Khaled; Pape, Ulrich-Frank; Reichman, Karl; Haslerud, Torjan; Ahmadzadehfar, Hojjat; Biersack, Hans-Jürgen; Nagarajah, James; Ezziddin, Samer
    Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotate
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 41, 2014, Nr. 3, S. 505 – 510
    DOI
  • Köninger, Angela; Koch, L; Edimiris, P; Enekwe, A; Nagarajah, James; Kasimir-Bauer, Sabine; Kimmig, Rainer; Strowitzki, T; Schmidt, Börge
    Anti-Mullerian Hormone : an indicator for the severity of polycystic ovarian syndrome
    In: Archives of Gynecology and Obstetrics, Jg. 290, 2014, Nr. 5, S. 1023 – 1030
    DOI
  • Jentzen, Walter; Hoppenbrouwers, Jan; van Leeuwen, Paul; van der Velden, Daan; van de Kolk, Rudie; Pöppel, Thorsten; Nagarajah, James; Brandau, Wolfgang; Bockisch, Andreas; Rosenbaum-Krumme, Sandra
    Assessment of Lesion Response in the Initial Radioiodine Treatment of Differentiated Thyroid Cancer Using 124I PET Imaging
    In: Journal of Nuclear Medicine (JNM), Jg. 55, 2014, Nr. 11, S. 1759 – 1765
    DOI (Open Access)
  • Jentzen, Walter; Richter, Marion; Nagarajah, James; Pöppel, Thorsten; Brandau, Wolfgang; Dawes, Colin; Bockisch, Andreas; Binse, Ina
    Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy 124I PET/CT imaging
    In: EJNMMI Physics, Jg. 1, 2014, Nr. 1, 100
    DOI (Open Access)
  • Wetter, Axel; Nensa, Felix; Schenck, Marcus; Heusch, Philipp; Pöppel, Thorsten; Bockisch, Andreas; Forsting, Michael; Schlosser, Thomas Wilfried; Lauenstein, Thomas; Nagarajah, James
    Combined PET Imaging and Diffusion-Weighted Imaging of Intermediate and High-Risk Primary Prostate Carcinomas with Simultaneous [18F] Choline PET/MRI
    In: PLoS ONE, Jg. 9, 2014, Nr. 7, S. 0101571
    DOI (Open Access)
  • Ruhlmann, Marcus; Stebner, Vanessa; Görges, Rainer; Farahati, Jamshid; Simon, D; Bockisch, Andreas; Rosenbaum-Krumme, Sandra; Nagarajah, James
    Diagnosis of hyperfunctional thyroidn odules : Impact of US-elastography
    In: Nuklearmedizin = Nuclear Medicine, Jg. 53, 2014, Nr. 5, S. 173 – 177
    DOI
  • Wetter, Axel; Lipponer, Christine; Nensa, Felix; Heusch, P.; Rübben, Herbert; Altenbernd, J. C.; Schlosser, Thomas Wilfried; Bockisch, Andreas; Pöppel, Thorsten; Lauenstein, Thomas; Nagarajah, James
    Evaluation of the PET component of simultaneous [(18)F]choline PET/MRI in prostate cancer : comparison with [(18)F]choline PET/CT
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 41, 2014, Nr. 1, S. 79 – 88
    DOI
  • Bauer, Sebastian; Hilger, Ralf A.; Mühlenberg, Thomas; Grabellus, Florian; Nagarajah, James; Hoiczyk, M.; Reichardt, A.; Ahrens, M.; Reichardt, P.; Grunewald, S.; Scheulen, Max Ernst; Pustowka, A.; Bock, E.; Schuler, Martin; Pink, D.
    Phase i study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors
    In: British Journal of Cancer (BJC), Jg. 110, 2014, Nr. 5, S. 1155 – 1162
    DOI (Open Access)
  • Ezziddin, Samer; Adler, Linda; Sabet, Amir; Pöppel, Thorsten; Grabellus, Florian; Yüce, Ali; Fischer, Hans Peter; Simon, Birgit; Höller, Tobias; Biersack, Hans-Jürgen; Nagarajah, James
    Prognostic stratification of metastatic gastroenteropancreatic neuroendocrine neoplasms by 18F-FDG PET : Feasibility of a metabolic grading system
    In: Journal of Nuclear Medicine (JNM), Jg. 55, 2014, Nr. 8, S. 1260 – 1266
    DOI (Open Access)
  • Wetter, Axel; Lipponer, Christine; Nensa, Felix; Heusch, Philipp; Rübben, Herbert; Schlosser, Thomas Wilfried; Pöppel, Thorsten; Lauenstein, Thomas; Nagarajah, James
    Quantitative evaluation of bone metastases from prostate cancer with simultaneous [18F] choline PET/MRI : combined SUV and ADC analysis
    In: Annals of Nuclear Medicine, Jg. 28, 2014, Nr. 5, S. 405 – 410
    DOI
  • Wieder, Hinrich A.; Tekin, G.; Rosenbaum-Krumme, Sandra; Klode, Joachim; Altenbernd, Jens; Bockisch, Andreas; Nagarajah, James
    18FDG-PET to assess recurrence and long term survival in patients with malignant melanoma
    In: Nuklearmedizin = Nuclear Medicine, Jg. 52, 2013, Nr. 5, S. 198 – 203
    DOI
  • Sabet, Amir; Nagarajah, James; Dogan, Ahmet Semih; Biersack, Hans-Jürgen; Sabet, Amin; Guhlke, Stefan; Ezziddin, Samer
    Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions? : Insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors
    In: EJNMMI Research, Jg. 3, 2013, Nr. 1, 82
    DOI (Open Access)
  • Thiering, Bastian; Nagarajah, James; Lipinski, Hans Gerd
    Spatial reconstruction of human thyroid based on ultrasound and CT image data fusion
    In: Biomedical engineering = Biomedizinische Technik, Jg. 58, 2013, Nr. Suppl.1
    DOI
  • Rosenbaum-Krumme, Sandra; Nagarajah, James; Ruhlmann, Marcus; Bockisch, Andreas; Jentzen, Walter
    124I-PET/CT images of differentiated thyroid cancer patients : Distinguishing lymph node metastases from thyroid remnants using kinetic quantities
    In: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 6, S. 213 – 216
    DOI
  • Hartung-Knemeyer, V.; Müller, Stefan; Nagarajah, James; Lahner, Harald; Bröcker-Preuß, Martina; Bockisch, Andreas; Görges, Rainer
    Assay-Abhängigkeit der Calcitonin- Zielbereiche für „biochemisch geheilte“ Patienten mit medullärem Schilddrüsenkarzinom
    In: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 4, S. 125 – 132
    DOI
  • Kraeber-Bodéré, Françoise; Carlier, Thomas; Naegelen, Valérie Meresse; Shochat, Eliezer; Lumbroso, Jean; Trampal, Carlos; Nagarajah, James; Chua, Sue; Hugonnet, Florent; Stokkel, Marcel; Gleeson, Fergus; Tessier, Jean
    Differences in the biologic activity of 2 novel MEK inhibitors revealed by¹⁸F-FDG PET: Analysis of imaging data from 2 phase I trials
    In: Journal of Nuclear Medicine (JNM), Jg. 53, 2012, Nr. 12, S. 1836 – 1846
    DOI
  • Rosenbaum-Krumme, Sandra; Freudenberg, Lutz; Jentzen, Walter; Bockisch, Andreas; Nagarajah, James
    Effects of rosiglitazone on radioiodine negative and progressive differentiated thyroid carcinoma as assessed by 124I PET/CT imaging
    In: Clinical Nuclear Medicine, Jg. 37, 2012, Nr. 3
    DOI
  • Rosenbaum-Krumme, Sandra; Wieduwilt, M.; Nagarajah, James; Bockisch, Andreas; Jentzen, Walter
    Estimation of tumour mass in patients with differentiated thyroid carcinoma using serum thyroglobulin
    In: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 6, S. 217 – 222
    DOI
  • Nagarajah, James; Dannat, T.; Hartung, Verena; Bockisch, Andreas; Rosenbaum-Krumme, Sandra
    F-fluoride PET/CT for bone scanning, Role of attenuation correction
    In: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 3, S. 84 – 87
    DOI
  • Grabellus, Florian; Nagarajah, James; Bockisch, Andreas; Schmid, Kurt Werner; Sheu, Sien-Yi
    Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma
    In: Clinical Nuclear Medicine, Jg. 37, 2012, Nr. 2, S. 121 – 127
    DOI
  • Sabet, A.; Ezziddin, K.; Hense, Jörg; Ahmadzadehfar, H.; Nagarajah, James; Thorsten, P.; Guhlke, S.; Biersack, Harald Reiner; Ezziddin, S.
    Long-term hematotoxicity after peptide receptor radionuclide therapy with 177Lu-octrotate
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 39, 2012, Nr. Suppl. 2, S. 233
  • Bauer, Sebastian; Hilger, Ralf A.; Grabellus, Florian; Nagarajah, James; Hoiczyk, M.; Reichardt, A.; Ahrens, M.; Pink, D.; Mühlenberg, Thomas; Scheulen, Max Ernst; Schuler, Martin; Reichardt, P.
    Phase I trial of panobinostat (P) and imatinib (IM) in patients with treatment-refractory gastrointestinal stromal tumors (GIST)
    In: Journal of Clinical Oncology (JCO), Jg. 30, 2012, Nr. Suppl. 15, S. 10032
  • Rosenbaum-Krumme, Sandra; Bockisch, Andreas; Nagarajah, James
    Pioglitazone therapy in progressive differentiated thyroid carcinoma
    In: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 4, S. 111 – 115
    DOI
  • Hartung-Knemeyer, Verena; Nagarajah, James; Jentzen, Walter; Ruhlmann, Marcus; Freudenberg, Lutz; Stahl, Alexander R.; Bockisch, Andreas; Rosenbaum-Krumme, Sandra
    Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine : Predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapies
    In: Annals of Nuclear Medicine, Jg. 26, 2012, Nr. 9, S. 723 – 729
    DOI
  • Nagarajah, James; Farahati, Jamshid; Görges, Rainer; Grabellus, Florian; Bockisch, Andreas; Sheu-Grabellus, Sien-Yi
    Success rate of repeated fine needle aspiration biopsy of clinically suspicious thyroid nodules
    In: Nuklearmedizin = Nuclear Medicine, Jg. 51, 2012, Nr. 4, S. 116 – 118
    DOI
  • Nagarajah, James; Sheu-Grabellus, Sien-Yi; Farahati, Jamshid; Kamruddin, Kamer A.; Bockisch, Andreas; Schmid, Kurt Werner; Görges, Rainer
    Ultrasound-guided fine-needle aspiration biopsy of clinically suspicious thyroid nodules with an automatic aspirator : A novel technique
    In: Thyroid, Jg. 22, 2012, Nr. 7, S. 695 – 698
    DOI
  • Riegger, C.; Herrmann, J.; Nagarajah, James; Hecktor, J.; Kuemmel, Sherko; Otterbach, F.; Hahn, S.; Bockisch, Andreas; Lauenstein, Thomas; Antoch, G.; Heusner, Till Alexander
    Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 39, 2012, Nr. 5, S. 852 – 863
    DOI
  • Hahn, Steffen; Heusner, Till; Kümmel, Sherko; Ninger, Angelika Kö; Nagarajah, James; Müller, Stefan; Boy, Christian; Forsting, Michael; Bockisch, Andreas; Antoch, Gerald; Stahl, Alexander
    Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer
    In: Acta Radiologica, Jg. 52, 2011, Nr. 9, S. 1009 – 1014
    DOI
  • Nagarajah, James; Jentzen, Walter; Hartung, Verena; Rosenbaum-Krumme, Sandra; Mikat, Christian; Heusner, Till Alexander; Antoch, Gerald; Bockisch, Andreas; Stahl, Alexander
    Diagnosis and dosimetry in differentiated thyroid carcinoma using ¹²⁴I PET : Comparison of PET/MRI vs PET/CT of the neck
    In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 38, 2011, Nr. 10, S. 1862 – 1868
    DOI
  • Nagarajah, James; Sheu-Grabellus, Sien-Yi; Leitzen, C.; Hartung, V.; Schmid, Kurt Werner; Bockisch, Andreas; Görges, Rainer
    Optimierung der Schilddrüsen- Feinnadelpunktion : Automatischer Mikroaspirator versus manuelle Technik
    In: Nuklearmedizin = Nuclear Medicine, Jg. 50, 2011, Nr. 5, S. 189 – 194
    DOI
  • Stahl, Alexander R.; Heusner, Till Alexander; Hartung, Verena; Nagarajah, James; Bockisch, Andreas; Hahn, Steffen; Antoch, Gerald; Jentzen, Walter
    Time course of tumor SUV in¹⁸F-FDG PET of breast cancer: Presentation of a simple model using a single reference point for time corrections of tumor SUVs
    In: Journal of Nuclear Medicine (JNM), Jg. 52, 2011, Nr. 1, S. 18 – 23
    DOI

    • Abstracts

  • Fizazi, Karim; Morris, Michael J.; Shore, Neal D.; Chi, Kim N.; Crosby, Michael; De Bono, Johann S.; Herrmann, Ken; Roubaud, Guilhem; Nagarajah, James; Fleming, Mark T.; Lewis, Brian E.; Nordquist, Luke; Castellano, Daniel; Carnahan, Natalie; Ghebremariam, Samson; Hertelendi, Marianna; Sartor, Oliver
    Health-related quality of life and pain in a phase 3 study of [177Lu]Lu-PSMA-617 in taxane-naïve patients with metastatic castration-resistant prostate cancer (PSMAfore)
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 42, 2024, Nr. Suppl. 16, 5003
    DOI
  • Fizazi, K.; Morris, M.J.; Shore, N.D.; Chi, K.N.; Crosby, M.; de Bono, J.S.; Herrmann, Ken; Roubaud, G.; Nagarajah, James; Fleming, M.T.; Lewis, B.; Nordquist, L.T.; Castellano Gauna, D.E.; Carnahan, N.; Ghebremariam, S.; Hertelendi, M.; Sartor, O.
    Symptomatic skeletal events, health-related quality of life and pain in a phase III study of [177Lu]Lu-PSMA-617 in taxane-naive patients with PSMA-positive metastatic castration-resistant prostate cancer : Third interim analysis of PSMAfore
    ESMO Congress 2024, 13-17 September 2024, Barcelona, Spain,
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 35, 2024, Nr. Suppl. 2, S. S964 – S965
    DOI
  • Herrmann, Ken; Krause, B. J.; Rahbar, K.; Chi, K. N.; Morris, M. J.; Sartor, O.; Tagawa, S. T.; Kendi, A. T.; Vogelzang, N.; Calais, J.; Nagarajah, James; Wei, X. X.; Koshkin, V.; Beauregard, J.; Chang, B.; DeSilvio, M.; Messmann, R. A.; de Bono, J.; Fizazi, K.
    Health-related quality of life (HRQoL), pain and safety outcomes in the phase 3 VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine October ; 15-19, 2022 Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S55 – S56
    DOI (Open Access)
  • Kuo, P.; Yoo, D. C.; Avery, R.; Seltzer, M.; Calais, J.; Nagarajah, James; Weber, W. A.; Fendler, Wolfgang P.; Hofman, M. S.; Krause, B. J.; Catafau, A.; Kpamegan, E.; Brackman, M.; Kendi, A. T.
    VISION read criteria of 68Ga-PSMA-11 PET scans for patient eligibility to 177Lu-PSMA-617 therapy : a simple and reproducible methodology
    EANM‘22 ; 35th Annual Congress of the European Association of Nuclear Medicine ; October 15-19, 2022, Barcelona, Spain,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 49, 2022, Nr. Supplement 1, S. S129 – S130
    DOI (Open Access)
  • Fizazi, K.; Herrmann, Ken; Krause, B.J.; Rahbar, K.; Chi, K.N.; Morris, M.J.; Sartor, O.; Tagawa, S.T.; Kendi, A.T.; Vogelzang, N.J.; Calais, J.; Nagarajah, James; Wei, X.X.; Koshkin, V.S.; Beauregard, J-M.; Chang, B.; DeSilvio, M.; Messmann, R.A.; de Bono, J.
    Health-related quality of life (HRQoL), pain and safety outcomes in the phase III VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    In: Annals of Oncology. Amsterdam: Elsevier, Jg. 32, 2021, Nr. Suppl. 5, S. 627 – S628
    DOI (Open Access)
  • Binse, Ina; Pokladek, J.; Weber, M.; Theurer, S.; Jentzen, Walter; Nagarajah, James; Herrmann, Ken; Görges, Rainer
    BRAF Mutation Analysis for Initial Risk Stratification in High Risk Papillary Thyroid Carcinoma
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 45, 2018, Nr. Suppl. 1, S. 551
    DOI
  • Lütje, Susanne; Ruhlmann, Verena; Bellendorf, Alexander; Pöppel, Thorsten; Beiderwellen, Karsten; Heusch, P.; Schaarschmidt, B. M.; Quick, Harald H.; Nagarajah, James; Gomez, Benedikt
    Comparison of 18F-FDG-PET/MRI and 18F-FDG-PET/CT for initial staging in pulmonary carcinoma
    28th Annual EANM Congress of the European Association of Nuclear Medicine, 10-14 October 2015, Hamburg, Germany,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 42, 2015, Nr. Suppl. 1, S. S439 – S440
    DOI
  • Bellendorf, Alexander; Muller, S. P.; Bockisch, Andreas; Ezziddin, S.; Nagarajah, James; Best, Jan; Schelhorn, J.; Pöppel, Thorsten; Sabet, A.
    Safety and efficacy of selective internal radiotherapy with Y-90 glass-microspheres in patients with progressive hepatocellular carcinoma (HCC) after failure of transarterial chemoembolization (TACE)
    28th Annual EANM Congress of the European Association of Nuclear Medicine, 10-14 October 2015, Hamburg, Germany,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 42, 2015, Nr. Suppl. 1, S. 748
    DOI
  • Nagarajah, James; Grabellus, Florian; Hahn, Steffen; Bockisch, Andreas; Stahl, Alexander R.
    Does polymorphism of the glucose transporter-1 gene (GLUT1) modulate (18)FDG uptake and tumor aggressiveness in breast cancer?
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 37, 2010, Nr. Suppl. 2, S. 246
    DOI

    • Beiträge in Sammelwerken und Tagungsbänden

  • Nagarajah, James; Janssen, Marcel; Weber, Manuel; Jentzen, Walter; Kreissl, Michael C.
    PET imaging in thyroid cancer
    In: Nuclear Medicine and Molecular Imaging: Volume 3: PET studies / Signore, Alberto; Macapinlac, Homer; Treglia, Giorgio (Hrsg.). Amsterdam: Elsevier, 2022, S. 99 – 104
    DOI
  • Nagarajah, James; Jentzen, Walter; Stebner, Vanessa; Binse, Ina; Janssen, Marcel; Grewal, Ravinder K.
    Imaging of Differentiated Thyroid Cancer with Iodine-124 and F-18-FDG
    In: The Thyroid and Its Diseases: A Comprehensive Guide for the Clinician / Luster, Markus; Duntas, Leonidas H.; Wartofsky, Leonard (Hrsg.). Cham: Springer Science+Business Media, 2019, S. 199 – 204
    DOI
  • Thiering, Bastian; Nagarajah, James; Lipinski, Hans-Gerd
    Fusion von Szintigrafie und CT für die Schilddrüsendiagnostik
    In: Bildverarbeitung für die Medizin 2013: Algorithmen - Systeme - Anwendungen / Meinzer, Hans-Peter; Proceedings des Workshops vom 3. bis 5. März 2013 in Heidelberg. Berlin [u.a.]: Kluwer Academic Publishers, 2013, S. 223 – 228
    DOI
  • Pöppel, Thorsten; Binse, Ina; Bockisch, Andreas; Nagarajah, James; Antke, Christina
    Imaging of neuroendocrine tumors with SPECT
    In: SPECT: Technology, Procedures and Applications / Ahmadzadehfar, Hojjat; Habibi, Elham (Hrsg.). Hauppauge, NY: Nova Science Publishers, Inc., 2013
  • Hartung, Verena; Ruhlmann, Marcus; Bockisch, Andreas; Nagarajah, James
    Tumor imaging with 123/131I-MIBG SPECT
    In: SPECT: Technology, Procedures and Applications / Ahmadzadehfar, Hojjat; Habibi, Elham (Hrsg.). Hauppauge, NY: Nova Science Publishers, Inc., 2013

    • Bücher/Sammelwerke/Tagungsbände

  • Nagarajah, James
    Glucose Transporter 1 Express, Tumor Proliferation, and lodine/Glucose Uptake in Thyroid Cancer With Enphasis on Poorly Differented Thyroid Carcinoma
    Duisburg, Essen, 2012

    • Dissertation

  • Nagarajah, James
    124-I-Dosimetrie für Läsionen kleiner als 1 cm bei Patienten mit differenziertem Schilddrüsen-Karzinom : Phantomstudie und klinischer Vergleich Positronen-Emissions-Tomographie (PET)/Computertomographie (CT) versus PET-Magnetrsonanz-Tomographie (MRT)
    Duisburg, Essen, 2010

    • Poster / Posterbeiträge

  • Yazdanpanah, Omid; Calais, Jeremie; Chi, Kim N.; De Bono, Johann S.; Deymann, Sheila; El-Haddad, Ghassan; Herrmann, Ken; Fizazi, Karim; Ospina Gonzalez, Diego; Kendi, Ayse T.; Krause, Bernd J.; Morris, Michael J.; Nagarajah, James; Nordquist, Luke; Sartor, Alton Oliver; Rahbar, Kambiz; Tagawa, Scott T.; Vaishampayan, Nitin; Yue, Ye; Rezazadeh, Arash
    Efficacy of 177Lu-PSMA-617 with or without ARPIs for the treatment of mCRPC : VISION secondary analysis
    2025 ASCO Genitourinary Cancers Symposium, January 13-15, 2025, San Francisco, CA, USA,
    In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 43, 2025, Nr. 5, Supplement, 121
    DOI
  • Boy, Christian; Ezziddin, S.; Rosenbaum-Krumme, Sandra; Nagarajah, James; Fichtner, C.; Brandau, Wolfgang; Lauenstein, Thomas; Lahner, Harald; Sheu, Sien-Yi; Bockisch, Andreas; Poeppel, D.
    Lack of Somatostatin Receptor Subtype-2 (SSTR2) in the Normal Human Thyroid Gland at Protein Level : Apparent Discrepancy of Immunohistochemistry and Gender-Specific Uptake of 68Ga-DOTATOC?
    27th Annual Congress of the European Association of Nuclear Medicine, October 18–22, 2014, Gothenburg, Sweden,
    In: European Journal of Nuclear Medicine and Molecular Imaging. Berlin: Springer, Jg. 41, 2014, Nr. Suppl. 2, S. S411
    DOI